Search
for
Sort by
Research 451–480 of 1000+
- Sacituzumab Govitecan-Hziy (Trodelvy™)
- Hypoxia inducible factor-1α promotes trichogenic gene expression in human dermal papilla cells
- Comparison of the efficacy of topical minoxidil 5% and adenosine 0.75% solutions on male androgenetic alopecia and measuring patient satisfaction rate.
- Alopecia in three women of southeast asian descent with chronic renal failure: Possible association with erythropoietin use
- Delayed Diagnosis of Ectopic Thyroid Due to Ignored Borderline Result of Newborn Screening for Congenital Hypothyroidism
- Evaluating the efficacy and safety of combined microneedling therapy versus topical Minoxidil in androgenetic alopecia: a systematic review and meta-analysis
- Alopecia due to chemotherapeutics, hedgehog inhibitors, targeted antibody therapies and immune checkpoint inhibitors
- From Eye Care to Hair Growth: Bimatoprost
- Clinical Value Analysis of Pemetrexed Combined with Cisplatin in the Treatment of Non-Small Cell Lung Cancer
- Efficacy, Tolerability, and Superiority of Propylene Glycol-Free, North American Witch-Hazel (Hamamelis virginiana)-Based Solution of 5% Minoxidil Sulfate for the Treatment of Female Androgenetic Alopecia
- A study to assess the co-morbidities and complications of polycystic ovarian syndrome
- [A critical review of the results of clinical experimentation with topical minoxidil 2%].
- Safety and Efficacy of the Coadministration of Sildenafil and Finasteride
- Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer
- Health-related quality of life with sacituzumab govitecan in HR+/HER2− metastatic breast cancer in the phase III TROPiCS-02 trial
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Pharmacokinetic studies of minoxidil
- Topical Minoxidil
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Treatment of Keratosis Pilaris With 810-nm Diode Laser
- Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study
- Fixed-dose combination PRO 160/120 of sabal and urtica extracts improves nocturia in men with LUTS suggestive of BPH: re-evaluation of four controlled clinical studies
- Patient-Controlled Expansion: Applying a New Technique to Breast Reconstruction
- Dovobet ointment under occlusion overnight for troublesome scalp psoriasis
- A Clinical Evaluation of Guduchi (Tinospora cordifolia) and Yashtimadhu (Glycyrrhiza glabra) as Chemopreventive Agent in Cancer Treatment
- Hair analysis of formoterol as a novel tool to assess long‐term inhalation medication adherence: Data from the TRICOLON trial
- All Subcomponents of the Cutaneous Lupus Erythematosus Disease Area and Severity Index–Activity (CLASI-A) are Relevant to Identify and Detect Changes in Skin Activity
- Tamsulosin and Solifenacin : A Dynamic Duo in BPH Management
- Use of 5% Topical Minoxidil Application for Telogen Effluvium: An Open‐Label Single‐Arm Clinical Trial
- Guest Editor's Note